CCBL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.596370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.357700E-02
Normal-vs-Stage2
1.638020E-01
Normal-vs-Stage3
2.628200E-01
Normal-vs-Stage4
7.394400E-01
Stage1-vs-Stage2
3.568200E-01
Stage1-vs-Stage3
8.304000E-01
Stage1-vs-Stage4
6.144400E-02
Stage2-vs-Stage3
6.460000E-01
Stage2-vs-Stage4
3.034200E-02
Stage3-vs-Stage4
2.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.688840E-01
Normal-vs-AfricanAmerican
4.058100E-02
Normal-vs-Asian
1.969360E-01
Caucasian-vs-AfricanAmerican
2.528600E-01
Caucasian-vs-Asian
8.190800E-01
AfricanAmerican-vs-Asian
4.267000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.906370E-01
Normal-vs-Female
1.198360E-01
Male-vs-Female
7.739400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.071000E-01
Normal-vs-Age(41-60Yrs)
1.855220E-01
Normal-vs-Age(61-80Yrs)
1.515200E-01
Normal-vs-Age(81-100Yrs)
1.451580E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.025800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.489800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.599400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.057750E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.662800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.969600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.550400E-02
Normal-vs-Daily Drinker
1.025830E-01
Normal-vs-Weekly Drinker
1.170180E-02
Normal-vs-Occasional Drinker
2.078200E-01
Normal-vs-Social Drinker
5.757200E-01
Non Drinker-vs-Daily Drinker
9.692600E-01
Non Drinker-vs-Weekly Drinker
4.118400E-01
Non Drinker-vs-Occasional Drinker
8.528300E-02
Non Drinker-vs-Social Drinker
1.136030E-02
Daily Drinker-vs-Weekly Drinker
5.200800E-01
Daily Drinker-vs-Occasional Drinker
1.439810E-01
Daily Drinker-vs-Social Drinker
3.249600E-02
Weekly Drinker-vs-Occasional Drinker
2.142500E-02
Weekly Drinker-vs-Social Drinker
4.522200E-03
Occasional Drinker-vs-Social Drinker
3.191000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.006200E-01
Normal-vs-Grade 2
7.700600E-03
Normal-vs-Grade 3
1.985980E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.902300E-03
Grade 1-vs-Grade 3
3.541400E-03
Grade 1-vs-Grade 4
1.006200E-01
Grade 2-vs-Grade 3
3.907400E-01
Grade 2-vs-Grade 4
7.700600E-03
Grade 3-vs-Grade 4
1.985980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.070200E-01
Normal-vs-NonDiabetic
1.197610E-01
Diabetic-vs-NonDiabetic
7.456600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.066000E-01
Normal-vs-NoPancreatitis
1.195630E-01
Pancreatitis-vs-NoPancreatitis
5.838200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.345200E-01
Normal-vs-N1
1.142230E-01
N0-vs-N1
3.207200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.298200E-01
Normal-vs-TP53-NonMutant
1.770830E-01
TP53-Mutant-vs-TP53-NonMutant
6.964000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
